MannKind (MNKD) Shares Get One Lonely Upgrade from Weeden Amid 36% Sell-Off
Tweet Send to a Friend
Amid a flood of analyst downgrades today following news last night that the FDA has requested that the company conduct ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE